logo

For the Inventor, By the Inventor

Shell Knob, MO, United States of America

Rebecca O'Brien

This inventor holds 47 USPTO granted patents and 9 published patent applications and 10 EPO patents, primarily in Medical Devices. Top assignees: Pop Test LLC, Pop Test Abuse Deterrent Technology LLC, Pop Test Oncology, LLC. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rebecca O'Brien. Retrieved from https://idiyas.com/inventor/rebecca-o-brien

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 

% Patents Active = 66.0

 

Average Co-Inventor Count = 4.4

ph-index = 10

Forward Citations = 402(Granted Patents)


Company Filing History:

goldMedal11 out of 13 
 
Pop Test LLC
 patents
silverMedal10 out of 10 
 
Pop Test Abuse Deterrent Technology LLC
 patents
bronzeMedal10 out of 10 
 
Pop Test Oncology, LLC
 patents
4. 9 out of 9 
 
Pop Test Oncology Limited Liability Company
 patents
5. 3 out of 4 
 
Pop Test Cortisol LLC
 patents
6. 4 out of 834,513 
Other
 patents

Years Active: 2012-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Medical Devices
Therapeutic Agents
Wireless Communication
Intradermal Applicator
Bodily Fluids Monitoring
Diagnosis and Treatment
Drug Device
47 patents (USPTO):Explore Patents
1. 12263178 - Pharmaceutical compositions and methods (2025-04-01),
2. 12227727 - Medical devices and uses thereof (2025-02-18),
3. 12205696 - Drug device configured for wireless communication (2025-01-21),
4. 11702443 - Therapeutic agents and methods (2023-07-18),
5. 11576921 - Pharmaceutical compositions and methods (2023-02-14),
6. 11527315 - Drug device configured for wireless communication (2022-12-13),
7. 11364252 - System and method for diagnosis and treatment (2022-06-21),
8. 11224599 - Therapeutic agents and methods (2022-01-18),
9. 11116775 - System and method for diagnosis and treatment (2021-09-14),
10. 11040037 - Therapeutic agents and methods (2021-06-22),
11. 10653447 - Method of using an intradermal applicator for delivering a sensor within the skin (2020-05-19),
12. 10625063 - Drug device configured for wireless communication (2020-04-21),
13. 10537586 - System and method for diagnosis and treatment (2020-01-21),
14. 10517881 - Pharmaceutical compositions and methods (2019-12-31),
15. 10441762 - Drug device configured for wireless communication (2019-10-15),

Certainly! Here is the article about inventor Rebecca O'Brien:

Title: Shaping the Future of Healthcare: The Innovative Work of Inventor Rebecca O'Brien

Introduction:

Rebecca O'Brien, a prolific inventor hailing from Shell Knob, MO (US), has made significant contributions to the field of healthcare with her groundbreaking inventions. With a remarkable portfolio of 44 patents, Rebecca continues to drive innovation in the industry.

Latest Patents:

Rebecca's latest patents focus on revolutionary therapeutic agents and pharmaceutical compositions. Her invention of glucocorticoid receptor antagonists has paved the way for advanced treatments for infections, neoplasia, and fatty liver disease. Additionally, her work on cortisol blockers, such as glucocorticoid receptor antagonists, showcases their efficacy in combating viral infections, treatment-resistant prostate cancer, neoplasia, and infection related to injury or disease.

Career Highlights:

Rebecca O'Brien has left an indelible mark in the companies she has been associated with. Notably, she has worked with Pop Test LLC and Pop Test Oncology Limited Liability Company, spearheading research and development efforts to bring cutting-edge solutions to the market. Her innovative approach has revolutionized the healthcare landscape.

Collaborations:

Throughout her career, Rebecca has collaborated with esteemed professionals in the field, including Randice Lisa Altschul and Myron C Rapkin. These collaborations have led to synergistic efforts in research and invention, culminating in impactful breakthroughs.

Conclusion:

In conclusion, Rebecca O'Brien's dedication to innovation and her relentless pursuit of advancements in healthcare have solidified her position as a trailblazer in the industry. Her pioneering work continues to inspire and shape the future of healthcare, promising a brighter and healthier tomorrow.

If you have any more requests or need further information, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…